Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5085123
Max Phase: Preclinical
Molecular Formula: C42H71N5O6
Molecular Weight: 742.06
Molecule Type: Unknown
Associated Items:
ID: ALA5085123
Max Phase: Preclinical
Molecular Formula: C42H71N5O6
Molecular Weight: 742.06
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C#CCCCCCC[C@@H](C)C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N1CCC[C@H]1C(=O)N(C)[C@H](C(=O)N1CCC[C@H]1C(=O)CC)C(C)C)[C@@H](C)CC)C(C)C
Standard InChI: InChI=1S/C42H71N5O6/c1-13-16-17-18-19-20-23-31(9)38(49)43(10)35(28(4)5)40(51)45(12)37(30(8)14-2)42(53)47-27-22-25-33(47)39(50)44(11)36(29(6)7)41(52)46-26-21-24-32(46)34(48)15-3/h1,28-33,35-37H,14-27H2,2-12H3/t30-,31+,32-,33-,35-,36-,37-/m0/s1
Standard InChI Key: UAMRYBRZVSISFN-JCQCKKQTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 742.06 | Molecular Weight (Monoisotopic): 741.5404 | AlogP: 5.40 | #Rotatable Bonds: 20 |
Polar Surface Area: 118.62 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 6.00 | CX LogD: 6.00 |
Aromatic Rings: 0 | Heavy Atoms: 53 | QED Weighted: 0.12 | Np Likeness Score: 0.29 |
1. Yamano A, Asato Y, Natsume N, Iwasaki A, Suenaga K, Teruya T.. (2022) Odookeanynes A and B, Acetylene-Containing Lipopeptides from an Okeania sp. Marine Cyanobacterium., 85 (1.0): [PMID:34928625] [10.1021/acs.jnatprod.1c00915] |
Source(1):